Author

Julia A. Yaglom

Ariel UniversityORCID 0000-0002-8723-3506Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Anjana Edathil Kadangodan· 2 shared Michael Y. ShermaniD· 2 shared Vadim Levitt· 2 shared Valid GahramanoviD· 2 shared Albert PinhasoviD· 1 shared Andriy MarusykiD· 1 shared Arkadi HesiniD· 1 shared Bar Levi· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anjana Edathil Kadangodan

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 21, 2026

Systematic Generation of Mutations at Topoisomerase II Cleavage Sites Enables Cancer Adaptation to Doxorubicin Therapy

Valid Gahramanov, Anjana Edathil Kadangodan, Riham Barazi…·Michael Y. Sherman

The paper shows that cancer cells develop resistance to doxorubicin by accumulating mutations at Top2 cleavage sites, which prevent DNA damage and promote adaptation.

DOI 10.64898/2026.08.18.745411

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 23, 2026

Mega-frequency mutagenesis: generation of non-random precise mutations with extremely high frequency upon adaptation of cancer cells to drugs and stress

Victor Oleynik, Anjana Edathil Kadangodan, Valid Gahramanov…·Michael Y. Sherman

The paper shows that cancer cells generate non-random, high-frequency mutations during drug adaptation, enriched near transcription factor binding sites.

DOI 10.64898/2026.02.20.707073

humanwhole-genome sequencing

𝕏 PostBluesky